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The effect of interactions between urban air particulates (UAP) and carcinogens on bioavailability, metabolism, and DNA binding was studied in the isolat-
ed perfused and ventilated rat lung. The availability of benzo[alpyrene (B[alP) varied from 29 to 60% after intratracheal doses of carcinogen particulates
dissolving extremely slow and fast, respectively. Several cytochrome P450 enzyme (P450) inducers acting as 2,3,7,8-tetrachlorodibenzo[pldioxin-recep-
tor ligands have been identified in UAP extracts. fNaphthoflavone (BNF) was used to study how P450 induction alters the lung metabolism of carcino-
gens. Pretreatment increased the lung clearance for B[alP 8-fold and for 2-nitrofluorene (2NF) by a factor of four from 0.55 ± 0.06 ml/min to 2.37 ± 0.62
ml / min. Studies with the intact lung and with isolated lung cells show that carcinogen metabolism and pharmacokinetics depend both on the route of
exposure and dosage and on the distribution of specific enzymes. A cytochrome P45011B1 enzyme was detected in lung epithelial cells where it catalyzes
9-hydroxylation of 2NF. This rat lung 2NF-9-hydroxylation capacity increases in parallel with the age dependent up-regulation of lung P45011B1 expres-
sion. Both human and rat lung tissue have the capacity to form 9-hydroxy-2-nitrofluorene (9-OH-2NF) that is mutagenic. A BNF-inducible P4501A1 was
detected in endothelial and alveolar type 11 cells. Consequently, aromatic hydroxylation dominated when 2NF was dosed directly into the lung circulation.
Pretreatment of rats with BNF before intratracheal B[aIP dosage induced lung cytochrome P4501A1. The 7,8-dihydroxy-9,10-oxybenzo[alpyrene-
deoxyguanosine adduct and the total lung DNA adduct levels increased significantly from a peak level of 75 ±8 to 151 ± 19 fmole / mg DNA in lungs from
control and BNF pretreated rats, respectively. 3-Amino-1,4-dimethyk5H-pyridol-(4,3)-indole (TRP-P1) is a potent mutagen and carcinogen identified in UAP
extracts. Dietary BNF pretreatment of rats altered the [14CITRP-P1 distribution as analyzed by whole-body autoradiography. An enhanced retention was
observed in the small intestine, forestomach, esophagus, and lung. UAP catalyzes oxygen radical formation and deoxyguanosine-8-hydroxylation, which
were inhibited when the UAP samples were extracted with organic solvents or when they were incubated in the presence of desferroxamine. We there-
fore postulate that a polycyclic aromatic hydrocarbon autooxidation pathway may be responsible for generation of hydrogen peroxide, which may be
further converted to hydroxyl radicals through an iron-dependent reaction. - Environ Health Perspect 102(Suppl 4):147-156 (1994).
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Introduction
A complex mixture of carcinogens, enzyme
inducers, and metals are present in extracts
from urban air particulates (UAP) and several
interactions may occur after UAP deposition
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in the lung. It also is well documented that
exposure for particulate materials (PM) or
UAP increases the risk for respiratory tract
tumor development (1-3). Experimental
studies indicate that fibrous or particulate
materials can act as cocarcinogens (4,5) and
that PM induces chromosomal anomalies and
tumor transformation in cell culture (6-8).
The precise mechanism(s) behind this effect
essentially is unknown still, but the physico-
chemical adsorption of carcinogens to PM is
known to be important (9-11). Carcinogen
adsorption to PM has in fact been implicated
as an absolute prerequisite for respiratory tract
tumorigenesis in animals exposed to chemical
carcinogens through inhalation (12,13).
Exposure for polycyclic aromatic hydro-
carbon (PAH) carcinogens such as
benzo[a]pyrene (B[a]P) also has been relat-
ed to development of cancer in man
(14,15). It is well recognized that the
capacity to metabolize and generate reactive
metabolites is essential for initiation of
PAH tumorigenicity. Still, conflicting
results have been published on how induc-
tion of PAH-metabolizing enzymes affects
the risk for tumorigenicity in man. Because
UAP carry both carcinogens and potent
enzyme inducers, the question ofinduction
and carcinogen metabolism is highly rele-
vant for an understanding ofUAP-mediat-
ed carcinogenicity. In evaluating the
effects of carcinogens, it should be taken
into consideration, however, that carcino-
genesis is a result of several events. The
tumorigenesis is believed to start with a
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mutation caused by unrepaired lesions, or
DNA adducts formed between reactive car-
cinogen metabolites and DNA. Results
indicating a positive correlation between
enzyme inducibility or enzyme expression
to carcinogen activation and DNA adducts
have been published (16-18). Some con-
clusions point toward a positive correlation
between exposure levels, metabolic capaci-
ty, DNA adducts, and cancer risk; howev-
er, contradictory results exist (19,20).
Other factors such as different capacity to
repair DNA lesions also may modulate the
carcinogenic effect ofcarcinogens, which is
evident in individuals with limited DNA
repair capacity and an increased risk for
developing cancer (21,22).
In addition to DNA damage caused by
PAH metabolites, reactive oxygen species
also may mediate particulate associated tox-
icity (23-25). Oxygen radicals have been
implicated in DNA adduct formation
(26,27), in mutagenicity (28), and in car-
cinogenesis (29,30). It has been shown
that tumor-promoting asbestosis and other
PM catalyze formation ofhydroxyl radicals
(OH) and superoxide anions (02) (25).
Auto-oxidation of PAH and quinone gen-
eration has been suggested as another
mechanism through which such reactive
oxygen species may be formed (32). PAH
bound to UAP may thus generate DNA-
damaging oxygen radicals in parallel with
the metabolic cytochrome P450-dependent
PAH activation processes mentioned
above. In addition, active oxygen species
also may contribute to the second oxidative
step, the epoxidation, in PAH-diol-epoxide
formation. It is possible that oxygen radi-
cals thereby promote the formation of
DNA-bound carcinogens when PAH is
metabolized in the presence of an oxygen
radical generating system such as urban air
particulates or asbestosis fibers. A separate
study was designed to investigate this
hypothesis using authentic UAP samples as
an oxygen radical generating system.
Materials and Methods
Animals
Male 350 g Sprague-Dawley rats were
obtained from ALAB (Sweden) and were
given free access to food and water unless
otherwise stated.
Chemicals
[G-3H]-Benzo[a]pyrene (B[a]P), specific
activity 34 Ci/mmole, and unlabeled B[a]P
was obtained from Amersham (Arlington
Heights, IL) and from Sigma (St. Louis,
MO), respectively. Metabolite standards
B[a]P-9,10-diol, B[a]P-4,5-diol, B[a]P-7,8-
diol, 9-hydroxy-B[a]P, and 3-hydroxy-B[a]P
were obtained from IIT Research Institute
(Chicago, IL). The metabolite 7,8-dihy-
droxy-9,10-epoxy-7,8,9, 10-tetrahydro-
benzo[a]pyrene-[1,3-3H] (chemical reposi-
tory no. 312/567-4318, lot no. CR1O-12-
2), was obtained from the National Cancer
Institute Chemical Carcinogens Reference
Standard Repository (NCI, Bethesda, MD).
[14C]-Deoxyguanosine-5'-monophosphate,
specific activity of 500 mCi/mmole (CFB
89, batch 13), was obtained fromAmersham.
Hydroxylapatite (DNAgrade, Bio-Gel, HTP)
was obtained from Bio-Rad Laboratories
(Richmond, CA). Calf thymus DNA,
deoxyribonuclease I, proteinase K (type XI),
alkaline phosphatase (type III), and phos-
pho-diesterase (type II) were purchased from
Sigma.
UrbanAirParticulates
UAP samples were collected in Gothenburg,
Sweden (33) and were characterized as pre-
sented in previous studies (33-36). The
particulate samples are presented in the text
by abbreviations for UAP1, collected in
summer in a traffic tunnel; UAP2, collected
in the autumn in a rural area outside
Gothenburg; UAP3, collected in winter in
a traffic tunnel; and UAP4, collected in
winter at the street level.
Intratraceal Dosage
Three micrograms B[a]P was administered
intratracheally with a Hamilton syringe posi-
tioned at the bifurcation controlled by
X-ray monitoring during the operation.
B[a]P was administered as a suspension
with the carcinogen adsorbed onto UAP with
the carcinogen dissolved in an artificial alveo-
lar surfactant: dipalmitoyl phosphatidyl-
choline/phosphatidylglycerol (80:20, w/w)
and 1 mgalbumin/12 mgphospholipid.
Analyses of2-Niltrofluorene
andMetabolites
Analyses of 2-nitrofluorene (2NF) and its
metabolites was performed using a Laboratory
Data Control (LDC, Rivera Beach, FL) high-
pressure liquid chromatography (HPLC) sys-
tem, equipped with a Zorbax, C8 column
(DuPont,Wllmington, DE) (37).
DNAIsolationandDigestion
DNA was isolated from lung and liver
homogenates using chloroform/isoamylal-
cohol/phenol/ether extraction and hydrox-
ylapatite chromatography (36). DNA was
quantified by UV spectrophotometry and
DNA-bound [3H]B[a]P was quantified by
liquid scintillation counting.
Analysis ofBenzo[a]pyrene-DNA
Adducts
Lung and liver DNA from 5 to 10 animals
was digested enzymatically using deoxyri-
bonuclease (DNase) I, phosphodiesterase type
II and alkaline phosphatase type III, (38).
Released nucleoside DNA adducts were puri-
fied bySephadexLH-20 chromatography and
analyzed by HPLC on a C18 Radial Pak col-
umn connected in line with a liquid scintilla-
tion detector. The HPLC column was eluted
with a gradient from 42/58 vol/vol-%
methyl hydroxide/water (MeOH/H20) for
15 min, continued with a linear gradient for
60 min to 50/50 vol/vol-% MeOH/H20.
Standard DNA adducts were prepared by
incubating 9-hydroxybenzo[a]pyrene
(9-OH-B[a]P), [ 1 C]deoxyguanosine,
and rat liver microsomes and by reacting
anti-B[a]P-7,8-diol-9,10-epoxide with
[ C]deoxyguanosine (36).
Analysis ofmRNA
RNA extracts were prepared from whole tis-
sues or from isolated cell fractions according
to themethodpresentedbyChomcynski etal.
(39). Expression ofspecific P450 mRNAs
was then analyzed with use ofspecific cDNA
probes including a) a 758-bp clone corre-
sponding to the 3'-noncoding region of
cytochrome P4501A1 mRNA, b) a 265-bp
clone corresponding to the 3'-noncoding
region of cytochrome P450IA2 mRNA
(40), and c) a cDNA probe corresponding
to the 211-carboxyl-terminal amino acids of
P450IlB1 (41). Af-actin cDNAprobe was
obtained from Cleveland et al. (42). Equal
amounts (15 pg) of heat and formamide
denaturated RNA were loaded on 1.1%
agarose gels containing 25% formaldehyde
and electrophoresed and transferred to
nylon filters in 20 x SSPE (1 x SSPE = 180
mM sodium chloride, 10 mM sodium phos-
phate, pH 7.7, 1 mM EDIA). Filters were
then prehybridized at 42°C for 12 hr in a
buffer containing 40% formamide, 5 x
SSPE, 0.1% sodium dodecyl phosphate, 0.5
mg/ml yeast tRNA, and 2 x Denhardts
solution. Filter hybridization was per-
formed for 24 hr at 42°C in a hybridization
buffer containing 1 to 2 x 106 cpm/ml of
cDNA probe labeledwith deoxycytidine 5l
triphosphate-[ PI using a Multiprime
labeling kit (Amersham, England). After
hybridization, filters were washed and
autoradiographed.
CellSeparationbyElutriation
Lung cells were prepared as presented by
Devereux et al. (43,44) using a JE-6B rotor
equipped with a standard elutriation cham-
ber. Cell preparations for metabolism studies
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Figure 1. The total levels of rat lung benzo[a]pyrene (B[a]P) DNA adduct levels (fmole B[a]P/mg DNA) was
determined in DNA obtained from animals dosed B[a]P, which was adsorbed onto urban air particulates, releasing
the carcinogen with very fast (A), intermediate (B), and very slow (C) dissolution rates in vitro. Bar D represents
the lung DNA adduct levels after dosing B[a]P, which was dissolved in an artificial surfactant solution as
described in "Materials and Methods." The mean of 5 to 10 analysis is presented ± SD in each bar.
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were performed as described by Jones et al.
(45). Type II alveolar cells were identified
by a modified Papanicolaou staining method
(46). Nonciiated bronchiolar (Clara) cells
were identified by nitroblue tetrazolium
staining (47).
FlowCytometryMeasurements
Isolated cells were stained with mithramycin
or with propidium iodide for DNA quan-
tification and with fluorescein isothio-
cyanate for measurement ofprotein content.
The DNA and protein content was then
recorded on a laboratory built flow cytome-
ter (48), and the DNA histograms were
evaluated using a multichannel analyzer.
The 2 x N (2N, diploid) amount of DNA
was determined as presented elsewhere (49).
The channel number, corresponding to the
mean protein content per cell, was calculat-
ed using a computer program (50).
High-Prssure Liquid
ChromatographyAnalysis of
8-Hydroxydeoxguanonsine
Hydroxylated deoxyguanosine was analyzed
using an HPLC system equipped with a C18
column (51). The UV detector was set at
254 nm and was connected in line with an
electrochemical detector (Linear liquid chro-
matography-304) set in the oxidative mode
at + 0.600 V. In analysis ofDNAoxidation,
the ratio between 8-hydroxydeoxyguanosine
(8-OHdG) and deoxyguanosine (dG) was
used to express the degree ofDNA damage.
Standard 8-OHdG was synthesized in the
laboratory (52).
2-Nitroflourene Metabolismin Human
Lung TissueandRatLungCells
A total number of2 x 106 rat lung cells was
incubated with ['4C]2NF (1 pM) for 60 min
at 370 C. Incubations with 0.5 g/ml human
1' 4 lung tissue was added 0.5 nmole [ C]2NF.
Tissue for control incubations was denaturated
by boiling for 10 min in water. In a separate
series ofincubations, whole rat and human
lung tissue surgical resectate (normal tissue and
tumor, adenocarcinoma) were dissociated
mechanically and incubated with 2NF.
Incubationswiththethreedifferenttissues were
performed with or without preincubation with
the P450IIB1 and P4501A1 inhibitors, and
proadifen anda-naphthoflavone, respectively.
Resufts and Discussion
Availability ofParticulate-absorbed
Benzo[a]pyrene
The isolated perfused and ventilated rat lung
(IPL) was used to investigate interactions
between particulates and chemical carcino-
gen with metabolism, carcinogen bioavail-
ability, and DNA binding as the end point.
Release of B[a]P and rate of uptake into
the lung perfusion buffer differed signifi-
cantly between lungs administered with
different UAP samples. Lungs dosed with
10 30 60 min
Figure 2. High-pressure liquid chromatography (HPLC)
analysis on lung benzo[alpyrene (B[a]P) DNA adducts.
The DNA adducts were analyzed 4weeks after a single
intratracheal injection of B[a]P, which was adsorbed
onto different urban air particulates representing fast
(A), intermediate (B), and slow (C) B[a]P dissolution in
vitro. The DNA preparation, enzymatic digestion, and
HPLC analysis were performed as presented in
"Materials and Methods." The 9-hydroxy-4,5-oxy-
B[a]P-deoxyguanosine peak is marked with an arrow in
the panels above. The DNA analysis was performed
on DNA from 5 to 10 animals.
UAP1-adsorbed B[a]P released the carcino-
gen into the circulation with an absorption
half-life of 99 min. In contrast, lungs
dosed with microcrystalline, very fast dis-
solving B[a]P, released the carcinogen with
an absorption half-life of 14 min (35,36).
Lungs dosed with particulates releasing
B[a]P very fast released five times the level
of metabolites that was detected in per-
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Figure 3. Lung and liver cytochrome P450 mRNA lev-
els in rat tissues after and without intraperitoneal pre-
treatment with l-naphthoflavone (BNF) 24-hr before
sacrifice. The P450 specific mRNA induction response
was analyzed by the standard Northern blot procedure
using P45DIA1 and P45D1A2 specific cDNA probes, as
presented in "Materials and Methods." The figure
shows a representative result obtained with whole tis-
sue RNA extracts obtained from five animals that were
pooled in each group. The filter was probed with
cytochrome P45DIA1 specific [32P-labeled cDNA as
presented in the left panel and with a cytochrome
P45D1A2 specific cDNA probe as presented in the right
panel. The symbols B and C stand for BNF and control,
respectively, and Lu and Li denotes lanes added RNA
extracts from lung and liver tissues, respectively.
Control animals were administered one intraperitoneal
injection of corn oil only, 24 hr prior to sacrifice,
because corn oil was used as a vehicle for BNF.
fusate from lungs dosed with the UAP1.
This was believed to be caused by release
rate differences, because UAP1 releases
B[a]P extremely slow. When the B[a]P
dose was increased from 3 to 100 pg, only
a 2-fold difference remained, however, in
metabolite generation. This dose-depen-
dent metabolism was interpreted as an
effect of enzyme saturation at high B[a]P
doses (34). Because the metabolism and
absorption processes are parallel, we postu-
late that the carcinogen release or dissolu-
tion rate differences also affect the carcino-
gen DNA binding. If a slow rate of car-
cinogen dissolution avoids saturation ofthe
metabolism, more of the lung-deposited
B[a]P should be expected to react on lung
DNA (36). To evaluate this hypothesis, a
convolution-deconvolution algorithm was
used to predict differences in B[a]P
bioavailability from differences in in vitro
carcinogen desorption. UAP1-adsorbed
B[a]P was calculated thus to produce an
area under the concentration versus time
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Figure 4. Levels of total lung and liver benzo[axpyrene B[a]P-DNA adducts (fmole/mg DNA) were analyzed for a
period of 8 weeks after a single intratracheal dosage of B[a]P. The carcinogen was administered 24-hr after
intraperitoneal pretreatment with the 2,3,7,8-tetrachlorodibenzo[p]dioxin receptor ligand P-naphthoflavone (BNF)
dissolved in corn oil or after injection of corn oil only. Levels of DNA adducts in control rat lungs are represented
with square symbols. Lung DNA adduct levels in BNF-pretreated rats are shown as filled squares, while DNA
adduct levels in BNF-pretreated rats is presented with open symbols. Liver DNA adduct levels are represented
with open and filled circles in analogy with the presentation of lung DNA adduct levels. Each presented data point
is based on individual DNA analysis, with the mean value presented for DNA adduct levels determined in 5 to 10
animals. The mean value is plotted ± SD.
curve (AUC) in the lung perfusion buffer
of 7 ± 2 (pmole/ml/min). The corre-
sponding experimental AUC value reached
10 ± 4 (pmole/ml/min) (36). When
B[a]P was administered in an artificial alve-
olar surfactant, the carcinogen was released
from the lung into the circulation with a
maximal absorption rate and to an extent
ofover 80% at the 3-rg dose. In contrast,
UAP1-adsorbed B[a]P was released into
the lung circulation with less than 29% of
the dose. We conclude that the UAP is
able to potentiate the lung B[a]P dose by at
least a factor offour (36). When the level
oftotal lung B[a]P-DNA binding was ana-
lyzed in these lungs, the differences in
DNA adduct levels were in the same range
(36).
To assess if bioavailability and DNA-
binding differences also appear in vivo,
UAP-adsorbed B[a]P was dosed to rats by
intratracheal instillation and DNA adduct
levels were analyzed until 8 weeks after
dosage. The highest level of lung DNA
adducts, 8 weeks after dosage, was observed
in animals dosed with the UAP1 sample,
releasing B[a]P very slowly (Figure 1). In
the analysis of adduct identity, it was
observed that high levels ofthe carcinogenic
7,8-dihydroxy-9, 10-oxybenzo[a]pyrene-
deoxyguanosine (7,8-diOH-9,10-oxy-
dGuo) adduct was present in lung DNA
from animals dosed UAP with medium and
fast B[a]P dissolution rates (Figure 2).
EnzymeInductionand
DNAAdductFormation
Induction ofcarcinogen-metabolizing P450
enzymes (53) is mediated by a UAP-associ-
ated factor. This induction is likely to con-
stitute an important cocarcinogenic factor
caused by compounds with high affinity for
the 2,3,7,8-tetrachlorodibenzo[p]dioxin
(TCDD) receptor. Several compounds of
this class have been identified in urban air
and diesel exhaust particulate extracts (54).
It has, in fact, been demonstrated that the
rat lung is significantly more sensitive to
P450 induction than other tissues (55) and
that DNA damage localizes preferentially to
lung tissue even after topical application of
carcinogens (56). We observed that for-
mation of rat lung carcinogen-DNA
adducts increased after pretreatment with
the TCDD receptor ligand ,-naph-
thoflavone (BNF). Similar results were
observed in isolated perfused and ventilated
rat lungs dosed with B[a]P and 2NF. The
relationship between P450-enzyme induc-
tion and carcinogen-DNA binding was
therefore studied further. Interestingly, the
lung induction response, measured as
cytochrome P4501A1 mRNA levels, did
remain elevated for more than 4 days after
one intraperitoneal BNF dose. This was
significantly different from the induction
response in the liver, where the P450IAl
mRNA levels peaked and started to decline
already between 1 to 2 days after dosage
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(manuscript in preparation). In contrast to
the induction of both P4501A1 and
P450IA2 in the liver, no P4501A2 mRNA
could be detected in the rat lung (Figure
3). We believe that a biphasic lung
P450IA1 mRNA response reflects P450
enzyme induction in different lung cell cat-
egories.
The impact of BNF pretreatment on
P450 enzyme induction and on levels of
covalendy DNA-bound B[a]P was analyzed
in both lung and liver DNA. BNF pretreat-
ment significantly increased the peaklevel of
total lung DNA adducts from 75 ± 8
fmole/mg DNA to 151 ± 19 fmole/mg
DNA (p<0.05, n = 8 - 10). The lung
DNA adduct peak time also was delayed
from 3 days in control rats to 1 week after
B[a]P dosage in rats pretreated with BNF
(Figure 4). The levels of the total lung
DNA adducts remained significantly higher
for 8 weeks in BNF pretreated animals com-
pared to the adduct levels in control rats. A
slight, although not statistically significant,
decrease was detected in liver DNA-B[a]P
levels after BNF pretreatment (Figure 4).
Analogous observations also have been made
by others who have stated that flavones
appear to have opposing effects in the lung
and liver with respect to metabolic activa-
tion ofB[a]P. In fact, studies on the effects
ofthe flavone BNF on human B[a]P metab-
olism and epoxidation recently has been
published with results supporting our con-
clusion (53).
DNA adducts were analyzed by HPLC, as
shown in Figure 5. Figure 5A,Bshows elution
of [ C]-labeled DNA adducts used as
HPLC standards. When DNA from BNF-
treated rats was analyzed, we identified a
major lung DNA adduct as the carcinogenic
metabolite 7,8-diOH-9,10-oxy-B[a]P bound
to deoxyguanosine, 7,8-diOH-9, 10-oxy-
dGuo. One other prominent DNA adduct
present in lung DNA from control rats was
tentatively identified as 9-OH-4,5-oxy-
B[a]P-dGuo. The relative proportion
between these two DNA adducts differed
depending on both BNF pretreatment and
on the time interval from the time ofB[a]P
dosage until sacrifice. In DNA obtained
from control rat lungs, the 9-OH-4,5-oxy-
dGuo-DNA adduct dominated 1 week after
intratracheal B[a]P dosage (Figure 5C). In
contrast, 3 weeks later the 9-OH-4,5-oxy-
dGuo adduct and the 7,8-diOH-9,10-oxy-
dGuo adducts were present in approximately
equal amounts (Figure 5D). The effect of
BNF and P450IA1 enzyme induction also
was studied 1 week after B[a]P dosage when
the 7,8-diOH-9,10-oxy-dGuo-DNA adduct
represented more than 90% of the lung
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Figure 5. High-pressure liquid chromatography (HPLC) analysis of lung benzo[a]pyrene (B[a]PI DNA adducts in BNF
pretreated and control rats atvarious times after dosage of [3H]-B[a]P. (A) reference DNA adducts formed by incu-
bations with B[a]P, liver microsomal protein, and calf thymus DNA subjected to HPLC without prior (full scale) and
after (small scale) Sephadex LH-20 chromatography. (B) DNA adducts formed by incubation of 9-hydroxy-B[a]P
with [14C1-deoxyguanosine and liver microsomal protein from phenobarbital-treated rats. (C) Control rat lung. DNA
adducts analyzed 1 week afterthe B[a]P dose. (D) Control rat lung. DNA adducts analyzed 4weeks afterthe B[a]P
dose. (E) Lung DNA from BNF-treated rats analyzed 1 week after the B[a]P dose. (F) Lung DNA from BNF-treated
rats analyzed 4 weeks after the B[a]P dose. The arrows in these figures show the elution time for 9-hydroxy-4,5-
oxy-B[a]P-[14C]-deoxyguanosine, which was used as retention time standard.
DNA adduct level (Figure 5E).
Interestingly, 3 weeks later 40% of the
adduct level was identified again as 9-OH-
4,5-oxy-dGuo (Figure 5F). This transient
shift in DNA adduct identity may reflect the
transient P45OIA1 induction response
because the level oflung P450IA1, catalyzing
9,10- and 7,8-oxidation of B[a]P, prevails
only for alimited period oftime after asingle
BNF dose. If lung-deposited B[a]P is
retained longer in the lung, a proportion of
the carcinogen dose still may be available for
metabolism when the enzyme distribution
has returned to a low-P450IAI level with a
relatively high level ofP450IIB1 (53). The
relative DNA adduct retention times are
slightly different in Figure 5E,Ffrom the
retention times in other panels because of
technical reasons. Specific adductswere iden-
tified, however, from the retention time of
[ C]-labeled 9-OH-4,5-oxy-dGuo, used as
standard marker as indicatedwith an arrow.
Analysis of lung DNA shows that lungs
from animals dosed with UAP with slow
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Figure 6. Concentration versus time curves for 2-
nitrofluorene (2NF) in the isolated perfused and venti-
lated rat lung. The logarithmic 2NF concentrations ver-
sus time profiles were plotted after analysis of the
concentration of unmetabolized [14C]2NF in the recircu-
lating lung perfusion buffer. The carcinogen ['4C]2NF
was dosed either directly to the perfusion buffer(A) or
dosed through intratracheal instillation (B). The car-
cinogen was dissolved in an artificial surfactant solu-
tion, composed as presented in "Materials and
Methods," to be readily available in the lung. A 50-pg
dose of ['4C]2NF was administered. Lungs used in the
isolated perfused and ventilated lung studies were
obtained from control rats, dosed corn oil only (in the
figure marked control), and from rats injected with J-
naphthoflavone (in the figure marked BNF) 24 hr prior
to sacrifice. Each figure shows two representative
[14C]2NF perfusion-buffer concentration curves
obtained after intratracheal dosage or after dosage
directly into the recirculating lung perfusion buffer.
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Figure 7. Representative two-dimensional flow cytometryanalyses on rat lung cell fractions prepared by counter-
flow elutriation centrifugation containing parenchymal cells. Alveolar macrophages were eliminated prior to tis-
sue digestion and elutriation by repeated bronchioalveolar lavages. (A) Analysis of the fraction with the highest
numerical density of alveolartype 11 cells. (B)Analysis ofthe fraction with the highest numerical density of noncil-
iated bronchiolar(Clara) cells. The histological typing of cells was performed after selective staining, as described
in "Materials and Methods." The symbol G2 in thefigure marks outthe DNA peak representing type 11 cells in the
G2 phase of cell division, while the symbol S is added to mark alveolar type 11 cells in the DNA synthesis phase.
The symbol CC marks Clara cell peak. T-IIC marks out the peak representing alveolar type 11 cells, and (T-IIC)2 rep-
resents two-cell aggregates ofthe alveolartype 11 cells in the flowcytometrydiagram.
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B[a]P desorption contain a higher propor-
tion of 9-OH-4,5-oxy-dGuo when com-
pared to animals dosed with the UAP with
medium and fast B[a]P release (Figure 2). In
summary, both BNF pretreatment and UAP
adsorption of B[a]P alters identity, levels,
and persistence ofB[a]P-DNA adducts in rat
lungs.
AlimentaryCarcinogen Exposure
andEnzymeInduction
Urban air particulates deposited in the air-
ways are relocated to the gastrointestinal
tract through the mucociliary clearance
process. Particulate-adsorbed carcinogens
and enzyme inducers will follow the reloca-
tion pattern ofthe particulates. We studied,
therefore, the effects ofTCDD receptor lig-
and exposure on the small intestinal P450
enzyme activity with systemic distribution
oftryptophan pyrolysate product, 3-amino-
1,4-dimethyl-5H-pyridol-(4,3)-indole
(TRP-P1), and covalent binding ofB[a]P to
liver DNA as end points. We detected an
inducible level of P450IA1 in the proximal
small intestine (57). Interestingly, increas-
ing doses ofBNF produced a 15- to 30-fold
induction of the duodenal P4501A1 levels
before any induction could be detected in
the liver. At a BNF dose causing a 40-fold
induction of the intestinal P450IA1, the
liver enzyme level was induced only margin-
allywith less than a 2-fold increase. Because
UAP pass through the gastrointestinal tract
relatively fast and because desorption of
UAP-adsorbed compounds is a slow process,
we believe that any substantial systemic
P450 induction because ofalimentary expo-
sure ofUAP is most unlikely.
The effects of alimentary BNF exposure
was further studied in rats after per oral dos-
ing ofTRP-Pl. This potent mutagen and
carcinogen has been identified in the environ-
ment in UAP extracts at a concentration of
0.23 ± 0.17 pg/m3 (58). We therefore
investigated the effect of BNF exposure on
the autoradiographic distribution of orally
dosed TRP-P1 in rats with a 40-fold induc-
tion of the small intestinal P450IA1 enzyme
level. Following oral dosage ofboth inducer
and [14C]TRP-P1, we observed an enhanced
radioactivity retention in the small intestinal
epithelium, the forestomach, and the esopha-
gus. Interestingly, the lung also accumulated
TRP-P1-derived [ 4C]-radioactivity, repre-
senting TRP-P1 or metabolites (manuscript
in preparation).
Enzyme Induction and2-Nitroflourene
Metabolism in LungCells
The lung metabolism of2NF is induced by
pretreatment of rats with BNF as observed
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Figure 8. Metabolism of 2-nitrofluorene (2NF) was catalyzed by enzymes present in lung cell fractions that were
prepared by elutriation as. The panels show representative high-pressure liquid chromatography analyses of 2NF
and metabolites formed in vitro incubations performed as presented in "Materials and Methods." The retention
times are marked for the metabolite 9-hydroxy-2-nitrofluorene and for the monohydroxylated 2NF metabolite X-
hydroxy-2-nitrofluorene, which is oxidized by aromatic hydroxylation. (A) Metabolism in nonciliated bronchiolar
(Clara) cells obtained from control rats. (B) Metabolism in alveolar type 11 cells from control rats. (C) Metabolism
in Clara cells obtained 24 hr after intraperitoneal pretreatment of rats with 0-naphthoflavone. (D) Metabolism in
alveolar type 11 cells obtained 24 hr after intraperitoneal pretreatment of rats with )-naphthoflavone.
in the isolated perfused and ventilated rat
lung. The 2NF concentrations decline sig-
nificantly faster in the perfusion buffer
with lungs obtained from- BNF-pretreated
rats as compared to lungs from control ani-
mals (Figure 6A). When 2NF was admin-
istered by intratracheal administration, the
most significant change was a decreased
area under the 2NF concentration-time
curve, proportional to an enhanced pro-
duction ofmetabolites (Figure 6B) (37).
The effect of BNF pretreatment is not
uniformly distributed throughout the lung
because the lung cytochrome P450 enzymes
are concentrated to specific cell categories
(59,60). We also observed that rat lung
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Table 1. In vitro 8-hydroxylation of deoxyguanosine
residues in calf thymus DNA, catalyzed by urban air
particulates. a
Hydroxylation rate,
Experimental system 8-OH dG/ 1 x 105 dG/hr
UAP-1 (4) 9.5± 1.6 nm UAP-2(13) 3.2± 2.2
dG UAP-3 (5) 14.1± 2.5
UAP-4 (11) 11.7±1.6
8-OHdG UAP-5 (1) 4.9 ± 1.3
Crocidolite asbestos 11.5 ± 3.0
dC dA a + Catalase 100 pM 0.6 ± 0.3 a + Catalase boiled 5' 7.1 ± 2.3
a+FeCI2,3pM 23.7±1.9
n dT 18 a+FeCI2,30pM 36.2±3.1
a + Desferal, 1 mM 1.4 ± 2.4
a + Desferal, 1 mM 3.2 ± 1.4
a+H202,5pga 38±1.1
Abbreviations: 8-OH dG, deoxyguanosine 8-hydroxyla-
tion; UAP, urban air particulates; FeCI2, ferric chloride;
H202, hydrogen peroxide; HPLC, high-pressure liquid
* . . I . . . I . . . I . . . I . . . chromatography. aDeoxyguanosine 8-hydroxylation in
1 2 3 4 5 6 min incubations with 1 mg DNA/ml was determined by
HPLC. A control 8-hydroxylation rate was determined
in control incubations to a level of 1.3 8-OH dG analysis of enzymatically freed nucleosides and 8-hydroxydeoxyguanosine prepared residues per 1 x 1 dG, which is subtracted from the ted in vitro together with different urban air particulates. The high-pressure liquid data presented in Table 1. Data presented represents 3presented in "Materials and Methods," and the detector signals from UV and elec- the mean value ± SD from five experiments. b One
ented with different scales....temavau+SDfofiexprensOe ented with different scales. incubation with 5 pg H202 was included as a positive
control, causing deoxyguanosine 8-hydroxylation to
change to a level of 22.4± 1.4 8-OH dG/105 dG.
Clara cells and alveolar type II cells express
different P450 enzymes with the conse-
quence that the cells also metabolize 2NF
with different capacity and regiospecificity.
Pretreatment of rats with BNF-induced-
P450IA1-associated aromatic hydroxyla-
tion of 2NF, which appears to be highly
specific for the alveolar type II cells (manu-
script in preparation).
In contrast to the inducible P4501A1
enzyme, the constitutively expressed rat lung
P450IlB1 enzyme is regulated in an age
dependent mode in the rat (61). The lung
microsomal 2NF metabolism increased in
parallel with the age-dependent up-regula-
tion of lung P45011B1. This increased
capacity to form the mutagenic metabolite
9-OH-2NF changed steeply between three
to fourweeks after birth (61).
The lung-cell specific effects of BNF
pretreatment was studied after isolation of
lung cells by elutriation centrifugation.
The cell categories studied were alveolar
type II cells and Clara cells. The cell frac-
tions that were used for metabolic studies
or enzyme or mRNA analyses were ana-
lyzed by two-dimensional flow cytometry
(2DFC) to characterize the homogeneity of
the cells. The 2DFC analysis of two cell
fractions are displayed in Figure 7. Figure
7A shows a representative analysis ofdivid-
ing alveolar type II cells obtained from rat
lungs by elutriation centrifugation. The
solitary DNA peak, at the distance of2 x n
from the major peak, represents alveolar
type II cells in division. B shows Clara
cells. This cell fraction is contaminated
with two-cell aggregates of alveolar type II
cells. This contamination affects the 2NF
metabolism profile ofthis cell fraction.
A high capacity for 9-hydroxylation of
2NF was detected in incubations with
Clara cells (Figure 8A), which was in line
with the observation ofa Clara cell-specific
P450IIB1 expression analyzed by mRNA
Northern blot analysis (manuscript in
preparation). Alveolar type II cells also
possessed a considerable metabolic capaci-
ty but with preference for hydroxylation of
2NF on aromatic positions (X-ON-2NF).
The total 2NF metabolism rate increased
significantly in alveolar type II cells (Figure
8D) after pretreatment with BNF. A slight
induction of X-hydroxylation also was
seen, however, in Clara cell fractions
(Figure 8C). This inducible X-hydroxyla-
tion that was detected in the Clara cell frac-
tion probably is because ofthe presence of
alveolar type II cell aggregates in this frac-
tion, as observed in 2DFC analyses pre-
sented above. Significantly more X-OH-
2NF and polyhydroxylated 2NF metabo-
lites appeared in the HPLC chromatogram
after incubation of alveolar type II cells
obtained from BNF pretreated rats (manu-
script in preparation). This result was not
unexpected because cytochrome P450IA1
is known to metabolize the structurally
related carcinogen 2-acetylaminofluorene
with a high preference for aromatic ring-
hydroxylation (62,63). Pretreatment of
rats with BNF also increased the P450IA1
mRNA hybridization signal most exten-
sively in Northern blot analyses of RNA
extracts from type II cells (manuscript in
preparation). This combination of a
P4501A1 enzyme induction in alveolar type
II cells and the constitutive expression of
P45011B1 in the Clara cells affects the
elimination of lung deposited 2NF as
shown in the isolated perfused and ventilat-
ed lung (Figure 6B). The enhanced clear-
ance observed after intratracheal dosage of
2NF to lungs from BNF pretreated rats
probably is because of an induced level of
alveolar type II cell P450IA1.
The metabolism of 2NF in human lung
tissue was studied in incubations with 2NF
added to a surgical resectate containing an
adenocarcinoma and normal surrounding
tissue.
Human lung tissue enzymes catalyze main-
ly 9-hydroxylation; although, a low degree of
aromatic hydroxylation of 2NF also was
detected. The 9-hydroxylation pathway that
was catalyzed by human lung tissues was
inhibited by addition ofproadifen in analogy
with our previous observations on the rat
lung metabolism (manuscript in prepara-
tion). Similar enzymes generating similar
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2NF metabolites may be active thus both in
man and in the laboratory rat.
UrbanAirParticulates and
Oxygen Radicals
Reactive oxygen species are generated in
aqueous solutions of urban air particulates,
containing a complex mixture ofpolynuclear
aromatic hydrocarbons and their oxidation
products and derivatives together with min-
eral fibers, metal ions, and especially iron.
The ability ofdifferent UAP samples to cat-
alyze deoxyguanosine 8-hydroxylation (8-
OH-dG) was therefore analyzed by HPLC
chromatography, as shown in Figure 9 (51).
The UAP samples differed significantly in
terms of catalytical activity (Table 1). The
two most potent UAP samples did catalyze 8-
OH-dG formation with a capacity compara-
ble to tumor promoting asbestosis. It is not
known how reactive oxygen species were
formed, if through generation of hydrogen
peroxide, H202; superoxide anion, 02.- or
hydroxyl radicals, OH. Superoxide anions
and hydrogen peroxide have been identified
in cigarette smoke and other fumes, however
(64,65), and mayoriginate from oxidation of
aromatic polyphenols (31,32), which may
originate from autooxidation of PAH.
Hydrogen peroxide is of general lung-toxic
interest because it also induces squamous
metaplasia (66,67). Hydrogen peroxide is
readily converted to the hydroxyl radical
through the iron-catalyzed Fenton reaction:
2+ 3+ H202 + Fe - *0OH + OH + Fe
Because iron is present together with the
UAP samples, these theoretically should be
expected to possess the capacity to catalyze
hydroxyl radical formation. Inhibition of8-
OH-dG formation after addition of desfer-
roxamine to the UAP incubations supports
this hypothesis (Table 1).
UrbanAirParticulates and
Genotoxic Risk
The aim of this investigation was to study
several levels ofinteraction whereby urban air
particulates may influence metabolism avail-
ability and genotoxicity ofchemical carcino-
gens. The mechanism(s) involved in UAP
potentiation of carcinogenesis essentially is
unknown still. We have shown that UAP
adsorption ofB[a]P significandy alters several
key events (i.e., bioavailability ofthe carcino-
gen and formation and persistence ofspecific
DNA adducts). In animals dosed UAP-
adsorbed B[a]P characterized by slow car-
cinogen release, the lung DNA adduct levels
increased continuously for eight weeks. We
also observed that B[a]P adsorption to UAP
increased the DNA binding of B[a]P by a
factor offive. An increase, approximately 5-
fold overprevalence, also has been reported in
an epidemiological study of bronchogenic
carcinoma among ferrous foundry workers
(68,69). We therefore believe that the pre-
sent observations support the hypothesis that
UAPs may potentiate chemical carcinogen
toxicity at several levels.
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